ATS 2019 Virtual Final Program

910 Sensitivity of Multiple Breath Washout and Spirometry for Detection of Early Lung Disease in Children with Primary Ciliary Dyskinesia and Cystic Fibrosis: A Multicenter Study/ B. Kinghorn, M. Rosenfeld, S. McNamara, A. Genatossio, E. Sullivan, M. Siegel, I. Bauer, C. Clem, M. Davis, A. Griffiths, B. Wheeler, A. Mills, E. Thompson, S.D. Davis, M.W. Leigh, J.E. Pittman, Seattle, WA, p.A5688 911 A Comparison of Oscillometry Devices in Pediatric Asthma, Bronchopulmonary Dysplasia and Healthy Children/ M.P. Dumas, R.J. Dandurand, Z. Hantos, L.C. Lands, Montreal, Canada, p.A5689 912 Interpretation of Static Volumes in Caucasian and African-Caribbean Children/ N. Beydon, E. Dufetelle, J. Taytard, Paris, France, p.A5690 913 Differentiation of Normal and Abnormal Breathing Patterns and Work of Breathing (WOB) Indices in Children Using Machine Learning/ T.H. Shaffer, L. Ryan, A. Strang, R. Heinle, T. Rahman, M. Ratnagiri, Wilmington, DE, p.A5691 914 Establishment of Cut Off Values for Various Impulse Oscillometry (IOS) Parameters for Detection of Exercise Induced Bronchoconstriction (EIB) in Children with Asthma Aged 6 to 15 Years/ S. Gupta, K.R. Jat, J. Sankar, A. Mukherjee, R. Lodha, S. Kabra, New Delhi, India, p.A5692 915 The Benefit of Adding Impulse Oscillometry (IOS) Compared to NAEPP Guidelines Alone in Managing Asthma Is Dependent on IOS Cut Points/ P. Tirakitsoontorn, M. Crookes, W. Fregeau, N. Pabelonio, T. Morphew, H.-W.W. Shin, O. Guijon, S.P. Galant, Orange, CA, p.A5693 916 The Cotes Equation for Adjusting DLCO for Hemoglobin Is Preferred to the Dinakara Equation to Assess Risk of Pulmonary Complications Following Stem Cell Transplantation in Pediatric Patients/ A.V. Shah, S. Heidrich, J. Slaven, S. Jodi, C.L. Ren, Chicago, IL, p.A5694 917 Hypobaric Hypoxia (Altitude of Residence) and Age Determines Hemoglobin Levels in Peruvian Children Between 6 and 35 Months Old/ J.A. Leon-Abarca, R.A. Accinelli, Lima, Peru, p.A5695 918 Estimation of Pulmonary Capillary Blood Volume and Its Relation to Lung Volumes in Children with Sickle Cell Disease/ P. Mondal, D. Ofak, B.-J. Sankoorikal, C. Medbery, D. Kitch, D. Scicchitano, Hershey, PA, p.A5696 919 Validation of GLI-2012 Spirometry Reference Values in 3-11 Year Old Children from Northern and Central Italy/ E. Lombardi, C. De Pieri, E. Valentini, M. Arigliani, Florence, Italy, p.A7448 BASIC • CLINICAL • TRANSLATIONAL RAPID: RAPID ABSTRACT POSTER DISCUSSION SESSION C105 BRONCHIECTASIS: FROM CLINICAL PHENOTYPES TO TREATMENT 2:15 p.m. - 4:15 p.m. KBHCCD Ballroom A Four (Level 2) Abstract Summaries 2:15-2:45 Viewing/Discussion 2:45-4:15 Chairing: M.L. Metersky, MD, Farmington, CT R. Thomson, MBBS, PhD, Greenslopes, Australia M. Mirsaeidi, MD, Miami, FL 301 The Validity of Claims-Based Codes to Identify Pseudomonas Infection in Patients with Bronchiectasis in Medicare Data/ J.H. Ku, B. Chan, T.R. Aksamit, E. Henkle, K.L. Winthrop, Portland, OR, p.A5697 302 Bronchiectasis Cohort of the National Institute of Allergy and Infectious Disease (NIAID) Centralized Sequencing Initiative (CSI): Design, Methods and Initial Characteristics/ K. Kumar, M. Similuk, M. Walkiewicz, L. Jamal, D. Goldstein, R. May, C. Robinson, S. MacDonald, K.P. Fennelly, K.N. Olivier, Bethesda, MD, p.A5698 303 Clinical Phenotypes Among Patients with Bronchiectasis/ A. Basavaraj, L.N. Segal, A.S. Scott, S. Kitner, D. Harris, D.J. Addrizzo-Harris, D. Kamelhar, New York, NY, p.A5699 304 Airway Clearance in Non-Cystic Fibrosis Bronchiectasis: Analysis from the United States Bronchiectasis Research Registry/ A. Basavaraj, R. Choate, D.J. Addrizzo-Harris, T.R. Aksamit, A.F. Barker, C.L. Daley, L.A. Daniels, E. Eden, A.M. DiMango, K.P. Fennelly, D.E. Griffith, M.M. Johnson, M.R. Knowles, P.J. McShane, M.L. Metersky, P.G. Noone, A.E. O’Donnell, K.N. Olivier, M.A. Salathe, A. Schmid, B.M. Thomashow, G. TIno, G.M. Turino, K.L. Winthrop, New York, NY p.A5700 305 The Impact of Bronchiectasis as a Comorbid Condition on Outcomes of Hospitalization/ S. Hohmann, Chicago, IL, p.A5701 306 The Risk of Mortality Among Patients with Bronchiectasis at a Tertiary Care Center: Quality of Life and 6MWD/ J.C. Drew, K.A. Carey, K.N. Olivier, E. Ricotta, J. Kwan, C. Robinson, S.D. MacDonald, K.P. Fennelly, R. Prevots, Bethesda, MD, p.A5702 307 Prospective Monitoring of Patients with Bronchiectasis/ G. Ignatova, V. Antonov, Chelyabinsk, Russian Federation, p.A5703 308 The Road of Risk Factors Development for Multi-Drug Resistant Pathogens in Bronchiectasis Exacerbations: How Far to Severe Multi-Drug Resistant Pathogens Associated Bronchiectasis Exacerbations/ A.S. Sadigov, S. Akhundov, A. Agayeva, Baku, Azerbaijan, p.A5704 309 Nocardia Infections in Immunocompetent Patients with and Without Bronchiectasis/ A. Garrett, Scottsdale, AZ, p.A5705 310 Pseudomonas Aeruginosa Is Associated with Greater Frequency of Exacerbations Among Patients with Non-Cystic Fibrosis Bronchiectasis in the United States/ G.A. Stone, C.M. Blanchette, R. Patel, E. Zacherle, J. Noone, R. Howden, D. Mapel, Research Triangle Park, NC, p.A5706 311 Effects of Complex Heterozygosity of CFTR and Ciliary Genes in Non-CF Bronchiectasis/ B. Bermingham, S. Patel, J. Nichols, D.P. Kirkpatrick, S.M. Rowe, G.M. Solomon, Birmingham, AL, p.A5707 312 Airways Mucus Pathogenesis in Patients with Non-Cystic Fibrosis Bronchiectasis and Primary Ciliary Dyskinesia/ K.A. Ramsey, G. Radicioni, S. Livengood, D. Hill, C. Ehre, N.E. Alexis, M.R. Knowles, P.G. Noone, L.A. Daniels, S.H. Donaldson, M. McGuckin, M. Kesimer, R.C. Boucher, Chapel Hill, NC, p.A5708 ATS 2019 • Dallas, TX 304 TUESDAY • MAY 21